You searched for metabolic diseases - Page 54 of 62

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

…of Valbiotis. “Its global reach, strategic intent to develop science-based nutritional health solutions, and focus on fighting metabolic disorders like diabetes will be instrumental.” Valbiotis’ lead candidate food supplement is…

February 6, 2020 - 2 minutesmins - By Jonathan Smith

Optics11 Life receives €5 million in funding for drug development

News and Trends 18 Jul 2022

FORTY51 Ventures closes $43M biotech fund and announces first investment

…needs suffering from metabolic obstructive sleep apnea. The fund is advised by a complementary founding team of three industry veterans, Sara Núñez-García, Sascha Oliver Bucher and Tamás Schweighoffer, who the…

July 18, 2022 - 3 minutesmins - By Jim Cornall

In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

The companies Genesis Therapeutics, ADARx Pharmaceuticals, and Abcuro bagged the biggest biotech investments in August 2023. Around the world, companies focused on immunology, genetic disorders, and metabolic disorders attracted the…

September 4, 2023 - 3 minutesmins - By Willow Shah-Neville

News and Trends 18 Dec 2018

Gut Bacteria Could Combat Obesity and Depression

…in this study gave a fecal transplant of healthy subjects to patients with the metabolic syndrome. The study found that only patients with a specific gut microbiota profile benefitted from…

December 18, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 5 Sep 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

…a gene therapy intended to treat another neurometabolic syndrome called mucopolysaccharidosis type I (MPS-I). The company reported that the two patients treated so far have experienced a correction of the…

September 5, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 May 2022

Evotec, Sernova in partnership to develop beta cell diabetes therapy

…lost beta cells has long been a focus for diabetes research. In 2010, Evotec acquired DeveloGen, a metabolic disease company and spinout from the Max-Planck Institute in Germany that had…

May 19, 2022 - 3 minutesmins - By Susannah Rodgers

In Depth 14 Feb 2024

The next leap in pet health: longevity drugs for dogs

…by improving dogs’ metabolic health to delay the onset and reduce the impact of age-associated diseases. “It’s a little bit more of a reversal mechanism. It’s not going to make…

February 14, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 12 Feb 2018

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development and commercialization of imeglimin, a new treatment for metabolic disorders like type 2 diabetes….

February 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

…for an undisclosed rare metabolic disease. “The opportunities the platform gives us are broad, hence such joint ventures enable us to scale the pipeline by combining our drug discovery platform…

May 29, 2020 - 3 minutesmins - By David Kirk

News and Trends 22 Jun 2023

FDA approves type 2 diabetes drug for children 10 and older

…improve outcomes for this population and supports our larger commitment to advance treatment options for people living with a range of cardiometabolic conditions.” Jardiance is not recommended in patients with…

June 22, 2023 - 3 minutesmins - By Jim Cornall

Orchard therapeutics gene therapy header

News and Trends 1 Nov 2018

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its Nasdaq IPO and is now reportedly worth $1.25B (€1B). This IPO propels Orchard to the…

November 1, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

…The technology could potentially tackle a plethora of seemingly unrelated diseases, including infections, metabolic disorders, and cancer. The Scottish investment firm Thairm Bio led the financing, with US-based Kineticos Ventures…

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

FORTY51 Ventures closes $43M biotech fund and announces first investment

The biggest private biotech investments in August 2023

Gut Bacteria Could Combat Obesity and Depression

Orchard’s Gene Therapy Improves Children’s Motor Ability

Evotec, Sernova in partnership to develop beta cell diabetes therapy

The next leap in pet health: longevity drugs for dogs

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

AI Drug Discovery Firm Exscientia Closes €54M Series C

FDA approves type 2 diabetes drug for children 10 and older

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!